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Abstract
Pd-catalysed CC bond formation is an essential tool within the pharmaceutical and agrochemical industries. Many of these reac-
tions rely heavily on polar aprotic solvents; however, despite their utility, these solvents are incompatible with the drive towards
more sustainable chemical synthesis. Herein, we describe the scope and limitations of an alternative to DMF derived from renew-
able sources (CyreneTM) in Sonogashira cross-coupling and Cacchi-type annulations.
Scheme 1: The Sonogashira reaction.
Introduction
The Sonogashira reaction [1,2] (Scheme 1) is a robust and
broadly applicable Pd-catalysed bond-forming process that,
alongside the SuzukiMiyaura reaction [3], has steadily become
an indispensible tool for CC bond formation in the pharmaceu-
tical industry [4]. While the Sonogashira reaction can be effec-
tively carried out in a variety of media [1,2], in the general
sense this process clearly relies upon the use of dipolar aprotic
solvents, in particular DMF. Indeed, some 41% of all Sono-
gashira reactions reported using aryl iodides can be linked to the
use of DMF as a solvent [5].
In this context, the sustainability movement within pharmaceu-
tical research and development strives to substitute solvents
that have regulatory and environmental issues for those with a
lower perceived risk. Indeed, solvent replacement has
been designated a key research area with numerous pharmaceu-
tical companies detailing their efforts towards a more sustain-
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able solvent selection as part of their overall sustainability
programmes [6-23].
Based on its associated regulatory issues [24], it is perhaps no
surprise that DMF continues to be a priority solvent for replace-
ment. With legislation surrounding the use of DMF becoming
increasingly stringent [24], numerous efforts have been made
towards the use of alternative media in the Sonogashira reac-
tion [25-30]. However, notwithstanding its issues, DMF is an
excellent solvent for the Sonogashira reaction and its replace-
ment frequently occurs at the expense of increased temperature
(and therefore potentially substrate compatibility), reaction
time, catalyst loading or the requirement for non-commercial/
expensive catalysts, and yield [25-30]. Consequently, poor
choice of solvent replacement can result in one of industrys
workhorse reactions becoming rather less predictable and
robust.
In this regard, dihydrolevoglucosenone (Cyrene, Figure 1),
accessed in two steps from cellulose [31,32], has been shown to
possess similar physical properties to those of DMF and other
dipolar aprotic solvents [31,32]. In addition to its renewability,
Cyrene, as yet, has no associated pernicious effects and could
potentially represent a direct and functional replacement in
many of the fundamental reactions that typically employ DMF
[31,32]. The replacement of solvents with regulatory issues with
bio-derived alternatives has provided a series of advances
within the cross-coupling arena [33], allowing efficient CC
bond formation via cornerstone Pd-based methods including
SuzukiMiyaura [34,35], MizorokiHeck [36,37], Sonogashira
[38], Stille [39], Hiyama reactions [40], and hydroformylation
reactions [41].
Figure 1: Cyrene vs. DMF  selected physical properties [31,32].
In the current study, we present the use of Cyrene as an alterna-
tive solvent (direct DMF replacement) for the Sonogashira reac-
tion, as well as related Cacchi-type annulations [42,43], with an
emphasis on scope and limitations of its application.
Results and Discussion
To explore the use of Cyrene in the context of the Sonogashira
cross-coupling, we established a simple benchmark reaction
using iodobenzene (1a) and phenylacetylene (2a) (Table 1).
A typical literature-derived catalyst system was employed
(Pd(PPh3)2Cl2 with CuI additive [44,45]) and conversion to
diphenylacetylene (3a) was monitored.
Table 1: Reaction optimisation and comparison with existing solvents.a
Entry Reaction conditions 3a (%)b
1 0.1 M, Et3N (3 equiv), 20 °C, 5 h 94
2 0.3 M, Et3N (3 equiv), 20 °C, 5 h 98
3 0.5 M, Et3N (3 equiv), 20 °C, 5 h 100
4 0.5 M, K3PO4 (3 equiv), 20 °C, 5 h 
c
5 0.5 M, Cs2CO3 (3 equiv), 20 °C, 5 h 
c
7 0.5 M, Et3N (1.1 equiv), 20 °C, 5 h 98
8 0.5 M, Et3N (1.1 equiv), 30 °C, 1 h 96
9d 0.5 M, Et3N (1.1 equiv), 30 °C, 1 h 81
10e 0.5 M, Et3N (1.1 equiv), 30 °C, 1 h 87
a1 (1 equiv, 0.25 mmol), 2 (1.05 equiv, 0.26 mmol), Pd(PPh3)2Cl2
(2 mol %), CuI (4 mol %), base (see table), Cyrene, temperature
(see table), time (see table), N2. 
bIsolated yield. cReaction mixture
solidified, product was not isolated. dTHF used as solvent. eDMF used
as solvent.
Pleasingly, high conversion to product was immediately ob-
served at room temperature in 5 h (94%, Table 1, entry 1).
This high conversion was consistent across several reaction
concentrations (Table 1, entries 2 and 3) allowing for a reduc-
tion in solvent volume, commensurate with the principles of
green chemistry [46,47].
In attempts to further limit waste, we scanned a series of bases
(see Supporting Information File 1); organic bases consistently
performed more effectively and alternatives to Et3N provided
no significant advantages. However, during this process we
identified some potential limitations of this emerging solvent.
Specifically, inorganic bases such as K3PO4 and Cs2CO3
(Table 1, entries 4 and 5) resulted in the generation of a solid
reaction mixture. Further analysis revealed that the aldol prod-
ucts 4a and 4b (Figure 2) were generated under specific reac-
tion conditions.
The manufacturers note that when using Cyrene, materials to
avoid are strong acids, and strong oxidising and reducing
agents. Since sensitivity to base was not specified, we surveyed
a range of bases at various temperatures to evaluate the limita-
tions of Cyrene under such conditions (Table 2).
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Figure 2: Aldol products 4a and 4b and single crystal X-ray structure of 4b.
Table 2: Evaluation of the base sensitivity of Cyrene.a
Entry Base Temp. (°C) Reaction (Y/N)b
1 KOAc
25 N
50 Y
100 Y
2 Pyridine
25 N
50 Y
100 Y
3 K2CO3
25 Y
50 Y
100 Y
4 DIPEA
25 N
50 N
100 Y
5 Cs2CO3
25 Y
50 Y
100 Y
6 Et3N
25 N
50 N
100 Y
7 K3PO4
25 Y
50 Y
100 Y
8 DBU
25 Y
50 Y
100 Y
9 KOH
25 Y
50 Y
100 Y
10 t-BuOK
25 Y
50 Y
100 Y
11 NaH
25 Y
50 Y
100 Y
aReaction conditions: base (0.07 mmol) and Cyrene (0.5 mL) stirred at
the indicated temeperature for 24 h before analysis by TLC and
1H NMR . bY = reaction occurs, N = no reaction. See Supporting Infor-
mation File 1.
Under these specific reaction conditions, with the exception of
Et3N and DIPEA, there was a clear base sensitivity displayed
by Cyrene in the presence of all bases when the temperature
was elevated above 25 °C. Organic bases such as pyridine
(Table 2, entry 2), DIPEA (Table 2, entry 4), and Et3N (Table 2,
entry 6) were tolerated at 25 °C with DIPEA and Et3N also
tolerated at 50 °C. DBU, however, was not tolerated at any tem-
perature (Table 2, entry 8). With the exception of KOAc
(Table 2, entry 1), all inorganic bases resulted in reaction with
the solvent at room temperature (Table 2, entries 3, 5, 7, and
911). The extent of the reaction varied from the generation of
additional components, such as 4a and 4b, to gelation or com-
plete solidification of the reaction mixture. However, in a
moderately basic reaction mixture (e.g., using Et3N) at mild
reaction temperatures this issue could be entirely avoided. As
such, optimisation of the Sonogashira process allowed com-
plete conversion and 96% isolated yield in 1 h at 30 °C
(Table 1, entry 8). Importantly, the Cyrene-based system com-
pared very favourably upon comparison with standard solvents
(THF and DMF; Table 1, entries 9 and 10, respectively).
Continuing with the primary investigation and with an opti-
mised set of reaction conditions, we sought to explore the
generality of Cyrene in the Sonogashira cross-coupling
(Scheme 2). Significantly, a broad range of functionalised aryl
and heteroaryl iodides were tolerated (Scheme 2a).
In addition, electron-deficient aryl bromides were accommo-
dated, although with some variation in yield (3c, 3l, 3o, 3n).
Functionality on the alkyne component was also typically well
tolerated (Scheme 2b). While 3i and 3j required an extended
reaction time, this was a substrate-specific problem for the use
of 2a with these ortho-substituted aryl iodides that was not
apparent for other alkyne/ortho-substituted iodoarene combina-
tions (Scheme 2c).
Judicious selection of reacting components also enabled the de-
velopment of a useful Cacchi-type annulation (Scheme 3)
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Scheme 2: Cyrene-based Sonogashira cross-coupling: Substrate scope. Isolated yields. aYield using DMF as solvent. b2 equiv of Et3N used. 
c24 h
reaction time.
[42,43]. Specifically, employing ortho-amino (5) or ortho-
hydroxyaryl iodides (6) in the Sonogashira process generated an
alkyne intermediate that, upon increasing the reaction tempera-
ture from 30 °C to 60 °C, could undergo 5-endo-dig cyclisation
to forge functionalised and pharmaceutically relevant indole,
benzofuran, and aza-indole scaffolds in a single operation
(7af) [48-52].
Finally, with the viewpoint of generality of DMF substitution
by Cyrene, the base/temperature sensitivity issue may have
potential implications for further applications of Cyrene within
well-used organic transformations. For example, the majority of
many other standard cross-coupling processes employ inorgan-
ic or organic bases and heat (e.g., SuzukiMiyaura, Heck). Ac-
cordingly, Cyrene may be projected to be incompatible with
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Scheme 3: Cacchi-type annulation of o-amino/hydroxy iodoarenes. Isolated yields. aYield using DMF as solvent.
standard conditions for these reactions and its use would neces-
sitate base-free or exceptionally mildly basic reaction condi-
tions. In contrast, amide-bond formation is the most practiced
reaction in the pharmaceutical industry [4] and these are
routinely performed in DMF at room temperature in the pres-
ence of organic bases [53]. As such, Cyrene may offer consider-
able potential in this area. However, additional work will be re-
quired to validate the practicality of Cyrene as a viable DMF
replacement in these applications.
Conclusion
In summary, we have developed a mild and robust method for
the Sonogashira reaction, employing the bio-derived and sus-
tainable alternative to DMF, Cyrene. In addition, we have
shown the capacity for extension of the utility of this new sol-
vent towards enabling the cascade synthesis of functionalised
indoles and benzofurans via a Cacchi-type annulation. Perhaps
more importantly, we have documented some of the limitations
of the use of Cyrene as a solvent, providing guidance emerging
in relation to the thermal and chemical (base) stabilities of this
promising green solvent.
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1. General  
All reagents and solvents were obtained from commercial suppliers and were used without further 
purification unless otherwise stated. Purification was carried out according to standard laboratory 
methods.1 
 
1.1 Purification of solvents 
Cyrene was supplied directly by Circa and used as obtained. DMF was dried by heating to reflux over 
previously activated 4 Å molecular sieves and distilling under vacuum before being purged with, and 
stored under N2 in a septum-sealed oven-dried flask over previously activated 4 Å molecular sieves. 
THF was obtained from a PureSolv SPS-400-5 solvent purification system and transferred to and 
stored in a septum-sealed oven-dried flask over previously activated 4 Å molecular sieves and purged 
with and stored under N2. CH2Cl2, Et2O, EtOAc, MeCN, and petroleum ether 40±60 °C for 
purification purposes were used as obtained from suppliers without further purification. 
 
1.2 Purification and drying of bases 
Et3N was dried by heating to reflux over previously activated 4 Å molecular sieves and distilling 
under vacuum before being purged with, and stored under N2 in a septum-sealed oven-dried flask over 
previously activated 4 Å molecular sieves. Inorganic bases were dried in a Heraeus Vacutherm oven 
at 60 °C under vacuum for a minimum of 24 h before use. 
 
1.3 Experimental details 
Reactions were carried out using conventional glassware (preparation of S1 and S2) or in sealed 5 mL 
microwave vials (optimization reactions and reactions for Schemes 2 and 3). The glassware was oven-
dried (150 °C) and purged with N2 before use. Purging refers to a vacuum/nitrogen-refilling 
procedure. Room temperature was generally ca. 18 °C. Reactions were carried out at elevated 
temperatures using a temperature-regulated hotplate/stirrer. 
 
1.4 Purification of products 
Thin layer chromatography was carried out using Merck silica plates coated with fluorescent indicator 
UV254. These were analyzed under 254 nm UV light or developed using a vanillin solution. Normal 
phase flash chromatography was carried out using ZEOprep 60 HYD 40-63 µm silica gel. Reverse 
phase flash chromatography was carried out using IST Isolute C18 cartridges. Strong cation-exchange 
purification was carried out using an SCX cartridge.  
 
1.5 Analysis of products 
Fourier transformed infrared (FTIR) spectra were obtained on a Shimadzu IRAffinity-1 machine. 1H, 
13C, 19F and 11B NMR spectra were obtained on a Bruker DRX 500 spectrometer (Avance III HD 
console, Ascend 500 MHz magnet, BBO smart probe) at 500 MHz, 126 MHz, 471 MHz and 160 
MHz, respectively. 1H NMR for the evaluation of the base sensitivity were obtained on a Bruker AV 
400 at 400 MHz. Chemical shifts are reported in ppm and coupling constants are reported in Hz with 
CDCl3 referenced at 7.26 (1H) and 77.0 ppm (13C) and DMSO-d6 referenced at 2.50 (1H) and 39.5 
(13C). High-resolution mass spectra were obtained through analysis at the EPSRC UK National Mass 
Spectrometry Facility at Swansea University RUDW*ODVJRZ8QLYHUVLW\¶V6FKRRORI&KHPLVWU\0DVV
Spectrometry Service. Crystal data was obtained at 123(2) K using an Oxford Diffraction Gemini 
instrument and monochromatic Mo radiation. 
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2. General experimental procedures 
General Procedure A: Optimized conditions 
 
 
For example, synthesis of 1,2-diphenylethyne, 3a. 
To an oven-dried 5 mL microwave vessel was added Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %) 
and CuI (1.9 mg, 0.01 mmol, 4 mol %). The vessel was then capped and purged with N2 before 
addition of Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), iodobenzene (27.9 µL, 
0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 equiv). The reaction mixture 
was heated to 30 °C and maintained at this temperature with stirring for 1 h before the vessel was 
vented, and decapped. The solution was then diluted with EtOAc (10 mL), and washed with water (2 
× 20 mL) and brine (2 × 20 mL). The organics were then passed through a hydrophobic frit and 
concentrated under reduced pressure to give a yellow oil, which was purified by flash chromatography 
(silica gel, 0±5% Et2O in petroleum ether) to afford the title compound as a white solid (44.5 mg, 
quant.). 
Xmax (solid): 3068, 1603, 1495, 1446 cm-1. 
1H NMR (CDCl3, 500 MHz): įdd, J = 7.2, 1.9 Hz, 4H), 7.36 (m, 6H). 
13C NMR (CDCl3, 126 MHz): į4, 128.3, 123.3, 89.4. 
HRMS: exact mass calculated for [M] (C14H10) requires m/z 178.0782, found m/z 178.0784. 
Characterisation data is consistent with literature reported values.2 
 
General Procedure B: Synthesis of indoles and benzofuran 
 
 
For example, synthesis of 2-phenyl-1-tosyl-1H-indole (7a). 
To an oven-dried 5 mL microwave vessel was added Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %),  
CuI (1.9 mg, 0.01 mmol, 4 mol %), and N-(2-iodophenyl)-4-methylbenzenesulfonamide (93 mg, 0.25 
mmol, 1 equiv). The vessel was then capped and purged with N2 before addition of Cyrene (0.5 mL, 
0.5 M), Et3N (104 µL, 0.75 mmol, 3 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 equiv). 
The reaction mixture was heated to 30 °C and maintained at this temperature with stirring for 1 h. The 
reaction was subsequently heated to 60 °C and maintained at this temperature for 6 h before the vessel 
was vented and decapped. The solution was then diluted with EtOAc (10 mL), and washed with water 
(2 × 20 mL) and brine (2 × 20 mL). The organics were then passed through a hydrophobic frit and 
concentrated under reduced pressure to give a yellow oil, which was purified by flash chromatography 
(silica gel, 0±15% EtOAc in petroleum ether) to afford the title compound as a white solid (78.4 mg, 
90%). 
Xmax (solid): 3073, 1368, 1169 cm-1. 
1H NMR (CDCl3, 500 MHz): įd, J = 8.4 Hz, 1H), 7.54±7.50 (m, 2H), 7.45 (t, J = 8.2 Hz, 4H), 
7.38 (t, J = 7.4 Hz, 1H), 7.31±7.28 (m, 3H), 7.06 (d, J = 8.1 Hz, 2H), 6.56 (s, 1H), 2.31 (s, 3H). 
13C NMR (CDCl3, 126 MHz): į142.2, 138.3, 134.7, 132.4, 130.7, 130.4, 129.2, 128.7, 127.5, 
126.8, 124.8, 124.3, 120.7, 116.7, 113.4, 21.5. 
HRMS: exact mass calculated for [M+H]+ (C21H18NO6S) requires m/z 348.1058, found m/z 348.1061. 
Characterisation data is consistent with literature reported values.3 
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3. Reaction optimization data 
3.1. Variation of concentration 
Reactions were carried out according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 
mmol, 2 mol %), CuI (1.9 mg, 0.01 mmol, 4 mol %), Cyrene (X M), Et3N (104 µL, 0.75 mmol, 3 
equiv), iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 
equiv). After stirring at 20 °C for 5 h, the reaction was subjected to the purification outlined in the 
General Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the desired compound as a 
white solid. 
 
Entry Concentration (M) Volume (mL) Isolated yield (%) 
1 0.3 0.83 98 
2 0.1 2.5 94 
3 0.5 0.5 100 
 
3.2. Variation of the base 
Reactions were carried out according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 
mmol, 2 mol %), CuI (1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Base (X equiv), 
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 equiv). 
After stirring at 20 °C for 5 h, the reaction was subjected to the purification outlined in the General 
Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the desired compound as a white solid. 
 
Entry Base (mass) Equiv Isolated yield (%) 
1a K3PO4 (159 mg) 3 - 
2a Cs2CO3 (245 mg) 3 - 
3 DIPEA (97 mg) 3 85 
4 Pyridine (59 mg) 3 0 
5 Et3N (28 mg) 1.1 98 
6 Et3N (38 mg) 1.5 94 
7 Et3N (51 mg) 2 92 
a
 Formation of solid Cyrene dimer ± product was not isolated 
 
3.3. Variation of time and temperature 
Reactions were carried out according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 
mmol, 2 mol %), CuI (1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 
mmol, 1.1 equiv), iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 
mmol, 1.05 equiv). After stirring at X °C for X h, the reaction was subjected to the purification 
outlined in the General Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the desired 
compound as a white solid. 
 
Entry Temp. (°C) Time (h) Isolated yield (%) 
1 20 1 86 
2 20 3 94 
3 20 5 98 
4 25 1 91 
5 30 1 96 
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3.4. Variation of solvent 
Reactions were carried out according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 
mmol, 2 mol %), CuI (1.9 mg, 0.01 mmol, 4 mol %), solvent (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 
mmol, 1.1 equiv), iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 
mmol, 1.05 equiv). After stirring at 30 °C for 1 h, the reaction was subjected to the purification 
outlined in the General Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the desired 
compound as a white solid. 
 
Entry Solvent Isolated yield (%) 
1 Cyrene 96 
2 THF 81 
3 DMF 87 
 
4. Base sensitivity study 
Base (0.07 mmol) was added to a test tube and Cyrene (0.5 mL) was added. The tube was then capped 
and the mixture stirred at X °C. After 24 h the reaction mixture was sampled and analysed by TLC 
(60% EtOAc in petroleum ether) and 1H NMR and the resulting spectrum compared with that of 
Cyrene.  
 
Base Mass (mg) 
Temperature  
(°C) 
Reaction 
(Y/N) 
Solid 
Formation 
KOAc 7 
25 N x 
50 N x 
100 N x 
Pyridine 6 
25 N x 
50 N x 
100 N x 
K2CO3 10 
25 N x 
50 N x 
100 Y x 
DIPEA 9 
25 N x 
50 N x 
100 N x 
Cs2CO3 23 
25 Y ¥ 
50 Y ¥ 
100 Y ¥ 
Et3N 7 
25 N x 
50 N x 
100 N x 
K3PO4 15 
25 Y x 
50 Y ¥ 
100 Y ¥ 
DBU 11 
25 Y ¥ 
50 Y ¥ 
100 Y ¥ 
KOH 4 25 Y ¥ 
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50 Y ¥ 
100 Y ¥ 
tBuOK 8 
25 Y ¥ 
50 Y ¥ 
100 Y ¥ 
NaH 2 
25 Y ¥ 
50 Y ¥ 
100 Y ¥ 
 
5. Compound characterisation data 
5.1. Preparation of intermediates 
S1: N-(5-Chloro-2-iodophenyl)-4-methylbenzenesulfonamide 
 
To a round-bottomed flask charged with 5-chloro-2-iodoaniline (1 g, 3.95 mmol, 1 equiv) was added 
a solution of 1:1 pyridine in CH2Cl2 (0.7 M, 40 mL) and the reaction mixture was cooled to 0 °C. 4-
Methylbenzenesulfonyl chloride (750 mg, 3.95 mmol, 1 equiv) was added portionwise, and the 
reaction mixture was allowed to slowly warm to room temperature and then stirred for 24 h. Upon 
completion of the reaction, water (80 mL) and CH2Cl2 (80 mL) were added. The reaction mixture was 
separated and the organics were washed with 1 N NaOH (2 × 40 mL), 1 N HCl (2×40 mL), and brine 
(2 × 40 mL). The organics were then passed through a hydrophobic frit and concentrated under 
reduced pressure to give a crude residue, which was purified by flash chromatography (silica gel, 0±
12% EtOAc in petroleum ether) to afford the title compound as an off white solid (890 mg, 52%). 
1H NMR (CDCl3, 500 MHzį±7.65 (m, 3H), 7.57 (d, J = 8.5 Hz, 1H), 7.27 (d, J = 8.0 Hz, 2H), 
6.88±6.80 (m, 2H), 2.42 (s, 3H). 
13C NMR (CDCl3, 126 MHzį
21.2.  
Characterisation data is consistent with literature reported values.4 
 
S2: N-(3-Iodo-5-nitropyridin-2-yl)-4-methylbenzenesulfonamide 
 
Prepared in two steps from 3-iodo-5-nitropyridin-2-amine: 
Step 1: To a 25 mL three-necked flask charged with 5-nitropyridin-2-amine (1 g, 7.1 mmol, 1 equiv), 
was added concentrated sulfuric acid (12 mL, 0.6 M) and potassium iodate (653 mg, 2.8 mmol, 0.4 
equiv) portionwise, before subsequent heating to 200 °C. Potassium iodide (1.18 g, 7.1 mmol, 1 
equiv) was then added dropwise as an aqueous solution (4 mL), and the reaction mixture was stirred 
at 200 °C for 1.5 h. Upon completion, the reaction mixture was allowed to cool to room temperature 
before the slow addition of saturated sodium bicarbonate solution (20 mL) and EtOAc (20 mL). The 
reaction mixture was separated and the organics were washed with an aqueous solution of saturated 
Na2S2O3 (2 × 30 mL). The organics were then passed through a hydrophobic frit and concentrated 
under reduced pressure to give a yellow solid, 3-iodo-5-nitropyridin-2-amine, which was used without 
further purification (1.64 g, 87 %). 
 
Step 2: To a 100 mL round-bottomed flask charged with 3-iodo-5-nitropyridin-2-amine (1.29 g, 4.86 
mmol, 1 equiv) was added THF (40 mL, 0.13 M) and the reaction mixture was cooled to 0 °C. 
NHTs
I
Cl
N NHTs
IO2N
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Sodium hydride (224 mg, 9.72 mmol, 2 equiv) was added portionwise and the reaction mixture was 
stirred at 0 °C for 20 minutes. 4-Methylbenzenesulfonyl chloride (1.09 g, 4.86 mmol, 1 equiv) was 
added portion wise, and the reaction mixture was allowed to slowly warm to room temperature and 
was stirred for 18 h. Upon completion of the reaction, water (50 mL) and CH2Cl2 (50 mL) were added 
and the reaction mixture was separated and the organics washed with 1 M NaOH (2 × 50 mL), 1 M 
HCl (2 × 50 mL), and brine (2 × 50 mL). The organics were passed through a hydrophobic frit and 
concentrated under reduced pressure to give a crude residue, which was purified by flash 
chromatography (silica gel, 0±30% EtOAc in petroleum ether) to afford the title compound as a 
yellow solid (1.43 g, 70%). 
Xmax (solid): 3581, 3268, 3064, 2919, 1571, 1444, 1320 cm-1. 
1H NMR (DMSO-d6, 500 MHz): įGJ = 2.6 Hz, 1H), 8.40 (d, J = 2.5 Hz, 1H), 7.74 (d, J = 8.1 
Hz, 2H), 7.21 (d, J = 8.0 Hz, 2H), 3.35 (bs, 1H), 2.32 (s, 3H). 
13C NMR (DMSO-d6, 126 MHz): į 161.9, 145.0, 142.3, 140.9, 140.7, 134.7, 128.9, 127.4, 86.7, 21.4. 
HRMS: exact mass calculated for [M+H]+ (C12H11IN3O4S) requires m/z 419.9509, found m/z 
419.9510. 
Characterisation data is consistent with literature reported values.4 
 
5.2. Products from Table 1 
3a: 1,2-Diphenylethyne 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 equiv). 
After 1 h, the reaction mixture was subjected to the purification method outlined in the General 
Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the title compound as a white solid 
(44.5 mg, quant.). 
Xmax (solid): 3068, 1603, 1495, 1446 cm-1. 
1H NMR (CDCl3, 500 MHz): įdd, J = 7.2, 1.9 Hz, 4H), 7.36 (m, 6H). 
13C NMR (CDCl3, 126 MHz): į4, 128.3, 123.3, 89.4. 
HRMS: exact mass calculated for [M] (C14H10) requires m/z 178.0782, found m/z 178.0784. 
Characterisation data is consistent with literature reported values.2 
 
5.3. Products from Scheme 2a 
3b: 1-Fluoro-4-(phenylethynyl)benzene 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 4-
fluoro-iodobenzene (28.8 µL, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the title compound as a white 
solid (48.8 mg, quant.). 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), DMF (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 4-fluoro-
iodobenzene (28.8 µL, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 equiv). 
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After 1 h, the reaction mixture was subjected to the purification method outlined in the General 
Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the title compound as a white solid 
(46.9 mg, 96%). 
Xmax (solid): 2921, 1595, 1508, 1217 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.55±7.50 (m, 4H), 7.38±7.33 (m, 3H), 7.05 (t, J = 8.7 Hz, 2H). 
13C NMR (CDCl3, 126 MHz): į (d, 1JCF = 249.6 Hz), 133.5 (d, 3JCF = 8.2 Hz), 131.6, 128.4, 
128.4, 123.3, 119.4 (d, JCF  = 3.4 Hz), 115.7 (d, 2JCF = 22.4 Hz), 89.1, 88.3. 
19F NMR (CDCl3, 471 MHz): į-110.98. 
HRMS: exact mass calculated for [M] (C14H9F) requires m/z 196.0688, found m/z 196.0689. 
Characterisation data is consistent with literature reported values.5 
 
3c: 1-Nitro-4-(phenylethynyl)benzene 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 4-
nitro-iodobenzene (62.3 mg, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the title compound as an off 
white solid (48.8 mg, quant.). 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 4-
nitro-bromobenzene (50.5 mg, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the title compound as an off 
white solid (14.6 mg, 28%). 
Xmax (solid): 3107, 2926, 2217, 1593, 1511 cm-1. 
1H NMR (CDCl3, 500 MHz): į8.22 (d, J = 8.9 Hz, 2H), 7.67 (d, J = 8.9 Hz, 2H), 7.58±7.54 (m, 2H), 
7.39 (dd, J = 5.3, 1.8 Hz, 3H). 
13C NMR (CDCl3, 126 MHz): į147.0, 132.3, 131.9, 130.4, 129.3, 128.6, 123.7, 122.1, 94.7, 87.6. 
HRMS: exact mass calculated for [M+H]+ (C14H10NO2) requires m/z 224.0712, found m/z 224.0714. 
Characterisation data is consistent with literature reported values.5 
 
3d: 1-Methoxy-4-(phenylethynyl)benzene 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 4-
iodoanisole (58.5 mg, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 equiv). 
After 1 h, the reaction mixture was subjected to the purification method outlined in the General 
Procedure (silica gel, 0±15% Et2O in petroleum ether) to afford the title compound as an off white 
solid (51.9 mg, quant.). 
Xmax (solid): 3014, 2841, 2217, 1509 cm-1. 
1H NMR (CDCl3, 500 MHz): įdt, J = 3.9, 2.1 Hz, 2H), 7.49±7.46 (m, 2H), 7.36±7.29 (m, 3H), 
6.88 (d, J = 8.8 Hz, 2H), 3.83 (s, 3H). 
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13C NMR (CDCl3, 126 MHz): į1, 131.5, 128.3, 127.9, 123.6, 115.4, 114.0, 89.4, 88.1, 
55.3. 
HRMS: exact mass calculated for [2M+H]+ (C30H25O2) requires m/z 417.1855, found m/z 417.1847. 
Characterisation data is consistent with literature reported values.5 
 
3e: 4-(Phenylethynyl)phenol 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (70 µL, 0.5 mmol, 2 equiv), 4-
iodophenol (55 mg, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 equiv). 
After 1 h, the reaction mixture was subjected to the purification method outlined in the General 
Procedure (silica gel, 0±10% Et2O in petroleum ether) to afford the title compound as an off white 
solid (32.6 mg, 68%). 
Xmax (solid): 3412, 3059, 1513, 1254 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.51 (dd, J = 7.7, 1.4 Hz, 2H), 7.43 (d, J = 8.6 Hz, 2H), 7.33 (m, 3H), 
6.81 (d, J = 8.6 Hz, 2H). 
13C NMR (CDCl3, 126 MHz): į155.7, 133.3, 131.5, 128.3, 127.9, 123.6, 115.7, 115.5, 89.2, 88.1. 
HRMS: exact mass calculated for [M+H]+ (C15H13O) requires m/z 209.0966, found m/z 209.1008. 
Characterisation data is consistent with literature reported values.6 
 
3f: 1-Methoxy-3-(phenylethynyl)benzene 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 3-
iodoanisole (29.8 µL, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 equiv). 
After 1 h, the reaction mixture was subjected to the purification method outlined in the General 
Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the title compound as a yellow oil (51.4 
mg, 99%). 
Xmax (liquid film): 2937, 2838 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.57±7.53 (m, 2H), 7.35 (dd, J = 4.9, 2.4 Hz, 3H), 7.27 (t, J = 7.9 Hz, 
1H), 7.15 (d, J = 7.6 Hz, 1H), 7.08 (s, 1H), 6.91 (dd, J = 8.3, 2.0 Hz, 1H), 3.83 (s, 3H). 
13C NMR (CDCl3, 126 MHz): į159.4, 131.7, 129.4, 128.4, 128.3, 124.3, 124.2, 123.2, 116.4, 114.9, 
89.3, 89.2, 55.3. 
HRMS: exact mass calculated for [M+Na]+ (C14H11O) requires m/z 195.0810, found m/z 195.0813. 
Characterisation data is consistent with literature reported values.2 
 
3g: 1-Chloro-3-(phenylethynyl)benzene 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 3-
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chloro-iodobenzene (30.9 µL, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the title compound as a yellow 
oil (53.5 mg, 82%). 
Xmax (liquid film): 3064, 2224, 884 cm-1. 
1H NMR (CDCl3, 500 MHz): į±7.51 (m, 3H), 7.41 (dt, J = 7.3, 1.4 Hz, 1H), 7.36 (dd, J = 4.9, 
1.7 Hz, 3H), 7.31 (dt, J = 8.0, 1.5 Hz, 1H), 7.29 (d, J = 7.5 Hz, 1H). 
13C NMR (CDCl3, 126 MHz): į4, 131.9, 131.6, 129.9, 129.8, 128.8, 128.7, 128.6, 125.2, 122.9, 
90.7, 88.1. 
HRMS: exact mass calculated for [M] (C14H9Cl) requires m/z 212.0393, found m/z 212.0395. 
Characterisation data is consistent with literature reported values.7 
 
3h: 1-Nitro-3-(phenylethynyl)benzene 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 3-
nitro-iodobenzene (62.3 mg, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the title compound as a white 
solid (55.2 mg, 99%). 
Xmax (solid): 3083, 2213, 1517, 1349 cm-1. 
1H NMR (CDCl3, 500 MHz): į±8.37 (m, 1H), 8.19 (m, 1H), 7.83 (d, J = 7.7 Hz, 1H), 7.56 (m, 
3H), 7.40 (m, 3H). 
13C NMR (CDCl3, 126 MHz): į, 129.4, 129.1, 128.5, 126.4, 125.2, 122.9, 122.2, 
91.9, 86.9. 
HRMS: exact mass calculated for [M+H]+ (C14H10NO2) requires m/z 224.0712, found m/z 224.0710. 
Characterisation data is consistent with literature reported values.5 
 
3i: 1-Methyl-2-(phenylethynyl)benzene 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodotoluene (31.8 µL, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 equiv). 
After 24 h, the reaction mixture was subjected to purification by reverse phase chromatography (C18 
cartridge, 20±65% MeCN in water) to afford the title compound as a yellow oil (40 mg, 83%). 
Xmax (liquid film): 3023, 2924, 2855, 2217, 1496 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.56±7.53 (m, 2H), 7.50 (d, J = 7.5 Hz, 1H), 7.35 (m, 3H), 7.24 (d, J = 
3.9 Hz, 2H), 7.17 (m, 1H), 2.52 (s, 3H). 
13C NMR (CDCl3, 126 MHz): į140.3, 131.9, 131.7, 129.6, 128.5, 128.5, 128.3, 125.7, 123.7, 123.2, 
93.5, 88.5, 20.9. 
HRMS: exact mass calculated for [M] (C15H12) requires m/z 192.0939, found m/z 192.0935. 
Characterisation data is consistent with literature reported values.5 
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3j: 1-Chloro-2-(phenylethynyl)benzene 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
chloro-iodobenzene (30.5 µL, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 
equiv). After 24 h, the reaction mixture was subjected to purification by reverse phase 
chromatography (C18 cartridge, 20±65% MeCN in water) to afford the title compound as a yellow oil 
(54.9 mg, quant.). 
Xmax (liquid film): 3060, 2926, 2224, 1495 cm-1. 
1H NMR (DMSO-d6, 500 MHz): įdd, J = 7.5, 1.7 Hz, 1H), 7.62±7.58 (m, 3H), 7.48±7.41 (m, 
5H). 
13C NMR (DMSO-d6, 126 MHz): į 1, 133.8, 131.9, 130.9, 129.9, 129.8, 129.3, 127.9, 122.4, 
122.3, 94.8, 86.4. 
HRMS: exact mass calculated for [M] (C14H9Cl) requires m/z 212.0393, found m/z 212.0385. 
Characterisation data is consistent with literature reported values.2 
 
3k: 2-(Phenylethynyl)thiophene 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodothiophene (27.6 µL, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the title compound as an off 
white solid (41.4 mg, 92%). 
Xmax (liquid film): 3088, 2204 cm-1. 
1H NMR (CDCl3, 500 MHz): į±7.50 (m, 2H), 7.35 (dd, J = 5.2, 1.9 Hz, 3H), 7.31±7.28 (m, 2H), 
7.02 (dd, J = 5.0, 3.8 Hz, 1H). 
13C NMR (CDCl3, 126 MHz): į, 131.4, 128.4, 128.4, 127.3, 127.1, 123.4, 122.9, 93.0, 82.6. 
HRMS: exact mass calculated for [M] (C12H8S) requires m/z 184.0347, found m/z 184.0348. 
Characterisation data is consistent with literature reported values.2 
 
3l: 2-Nitro-5-(phenylethynyl)pyridine 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 5-
bromo-2-nitropyridine (50.8 mg, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 
1.05 equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±15% Et2O in petroleum ether) to afford the title compound as a white 
solid (51.4 mg, 92%). 
Xmax (solid): 3058, 2219, 1532, 1348 cm-1. 
1H NMR (CDCl3, 500 MHz): į8.73 (d, J = 1.6 Hz, 1H), 8.26 (d, J = 8.4 Hz, 1H), 8.10 (dd, J = 8.4, 
2.0 Hz, 1H), 7.58 (dd, J = 7.7, 1.4 Hz, 2H), 7.44 ± 7.38 (m, 3H). 
s13 
 
13C NMR (CDCl3, 126 MHz): į154.8, 151.1, 141.8, 131.9, 129.8, 128.7, 126.7, 121.4, 117.7, 97.9, 
84.2. 
HRMS: exact mass calculated for [M+H]+ (C13H9N2O2) requires m/z 225.0664, found m/z 225.0670. 
 
3m: 5-Chloro-2-(phenylethynyl)pyridine 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 3-
chloro-6-iodopyridine (59.8 mg, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 
1.05 equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±5% Et2O in petroleum ether) to afford the title compound as a white 
solid (54.5 mg, quant.). 
Xmax (solid): 3040, 2221, 1493, 1459 cm-1. 
1H NMR (CDCl3, 500 MHz): į8.58 (d, J = 1.8 Hz, 1H), 7.67 (dd, J = 8.4, 2.4 Hz, 1H), 7.60 (dd, J = 
7.5, 1.9 Hz, 2H), 7.48 (d, J = 8.4 Hz, 1H), 7.40±7.36 (m, 3H). 
13C NMR (CDCl3, 126 MHz): į149.1, 141.5, 136.0, 132.1, 131.3, 129.2, 128.5, 127.7, 121.9, 90.4, 
87.6. 
HRMS: exact mass calculated for [M+H]+ (C13H9NCl) requires m/z 214.0418, found m/z 214.0421. 
 
3n: 2-(Phenylethynyl)-1,8-naphthyridine 
 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
bromo-1,8-naphthyridine (52.3 mg, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 
1.05 equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±65% Et2O in petroleum ether) to afford the title compound as a white 
solid (54.3 mg, 94%). 
Xmax (solid): 3049, 3008, 2211, 1601, 1498 cm-1. 
1H NMR (CDCl3, 500 MHz): į9.15 (s, 1H), 8.17 (d, J = 8.2 Hz, 2H), 7.69±7.64 (m, 3H), 7.48 (dd, J 
= 7.7, 3.9 Hz, 1H), 7.43±7.37 (m, 3H). 
13C NMR (CDCl3, 126 MHz): į156.1, 154.3, 146.9, 137.2, 136.6, 132.4, 129.5, 128.5, 125.4, 122.3, 
121.9, 91.6, 89.3. Quaternary carbon at ring junction not observed. 
HRMS: exact mass calculated for [M+H]+ (C16H11N2) requires m/z 231.0922, found m/z 231.0923. 
 
3o: 2-Chloro-6-(phenylethynyl)pyridine 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.5 mmol, 1.1 equiv), 2-bromo-
6-chloropyridine (48 mg, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
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General Procedure (silica gel, 0±10% Et2O in petroleum ether) to afford the title compound as an off 
white solid (52.3 mg, quant.). 
Xmax (solid): 3059, 2960, 2226, 1577, 1435 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.63 (t, J = 7.8 Hz, 1H), 7.60±7.56 (m, 2H), 7.44 (d, J = 7.6 Hz, 1H), 
7.37 (q, J = 5.7 Hz, 3H), 7.28 (d, J = 8.0 Hz, 1H). 
13C NMR (CDCl3, 126 MHz): į151.4, 143.6, 138.7, 132.1, 129.3, 128.5, 125.7, 123.6, 121.8, 90.7, 
87.5. 
HRMS: exact mass calculated for [M+H]+ (C13H9NCl) requires m/z 214.0424, found m/z 214.0427. 
1H NMR and HRMS data is consistent with literature reported values.8 
3p: 1-Methyl-5-(phenylethynyl)-1H-indole  
 
 
 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (2.6 mg, 0.004 mmol, 2 mol %), CuI 
(1.4 mg, 0.007 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (28 µL, 0.20 mmol, 1.1 equiv), 5-
iodo-1-methyl-1H-indole (47 mg, 0.18 mmol, 1 equiv), and phenylacetylene (21 µL, 0.19 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±10% Et2O in petroleum ether) to afford the title compound as an off 
white solid (27.7 mg, 67%). 
Xmax (solid): 3051, 2926, 2208, 1597, 1496 cm-1.  
1H NMR (CDCl3, 500 MHz): į7.85 (s, 1H), 7.57±7.54 (m, 2H), 7.41 (dd, J = 8.5, 1.2 Hz, 1H), 7.35 
(t, J = 7.2 Hz, 2H), 7.30 (t, J = 8.7 Hz, 2H), 7.08 (d, J = 3.1 Hz, 1H), 6.49 (d, J = 2.7 Hz, 1H), 3.80 (s, 
3H). 
13C NMR (CDCl3, 126 MHz): į136.4, 131.5, 129.8, 128.4, 128.3, 127.7, 125.2, 124.8, 124.1, 113.8, 
109.3, 101.3, 91.2, 87.0, 32.9. 
HRMS: exact mass calculated for [M] (C17H13N) requires m/z 231.1048, found m/z 231.1057. 
Characterisation data is consistent with literature reported values.9 
 
5.4. Products from Scheme 2b 
3q: Phenylethynylboronic acid, MIDA ester 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and ethynyl boronic acid, MIDA ester (47.5 mg, 0.263 
mmol, 1.05 equiv). After 1 h, the reaction mixture was subjected to the purification method outlined 
in the General Procedure (silica gel, 0±60% EtOAc in petroleum ether) to afford the title compound as 
an off white solid (61.3 mg. 95%). 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), DMF (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and ethynyl boronic acid, MIDA ester (47.5 mg, 0.263 
mmol, 1.05 equiv). After 1 h, the reaction mixture was subjected to the purification method outlined 
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in the General Procedure (silica gel, 0-60% EtOAc in petroleum ether) to afford the title compound as 
an off white solid (61.2 mg. 95%). 
Xmax (solid): 3025, 2198, 1768, 1493 cm-1. 
1H NMR (DMSO-d6, 500 MHz): į±7.48 (m, 2H), 7.42±7.37 (m, 3H), 4.32 (d, J = 17.1 Hz, 2H), 
4.15 (d, J = 17.1 Hz, 2H), 3.08 (s, 3H). 
 13C NMR (DMSO-d6, 126 MHz): į4, 129.1, 129.1, 122.9, 99.9, 61.9, 48.4. Carbon 
bearing boron not observed. 
11B NMR (DMSO-d6, 160 MHz): į 
HRMS: exact mass calculated for [M+NH4]+ (C13H16BN2O4) requires m/z 275.1202, found m/z 
275.1198. 
Characterisation data is consistent with literature reported values.10 
3r: Trimethyl(phenylethynyl)silane 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and ethynyltrimethylsilane (37 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±1% Et2O in petroleum ether) to afford the title compound as a 
colourless oil (44 mg, quant.). 
Xmax (liquid film): 2962, 2161, 1491, 1251 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.50±7.47 (m, 2H), 7.34±7.29 (m, 3H), 0.27 (s, 9H). 
13C NMR (CDCl3, 126 MHz): į131.9, 128.5, 128.2, 123.1, 105.1, 94.1, -0.01. 
HRMS: exact mass calculated for [M] (C11H14Si) requires m/z 174.0865, found m/z 174.0866. 
Characterisation data is consistent with literature reported values.11 
 
3s: 4-Phenylbut-3-yn-1-yl 4-methylbenzenesulfonate 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and 3-butynyl-p-toluenesulfonate (46.3 µL, 0.263 mmol, 
1.05 equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0-30% EtOAc in petroleum ether) to afford the title compound as a 
colourless oil (60.7 mg, 81%). 
Xmax (liquid film): 2924, 2980, 1493, 1361, 1176 cm-1.  
1H NMR (CDCl3, 500 MHz): į7.79 (d, J = 8.3 Hz, 2H), 7.32±7.28 (m, 3H), 7.28±7.23 (m, 4H), 4.16 
(t, J = 7.0 Hz, 2H), 2.75 (t, J = 7.0 Hz, 2H), 2.39 (s, 3H). 
 13C NMR (CDCl3, 126 MHz): į144.9, 132.9, 131.7, 129.9, 128.2, 128.2, 127.9, 122.9, 83.8, 82.7, 
67.8, 21.6, 20.4. 
HRMS: exact mass calculated for [M+Na]+ (C17H16O3SNa) requires m/z 323.0712, found m/z 
323.0702. 
Characterisation data is consistent with literature reported values.12 
 
3t: N,N-Dimethyl-3-phenylprop-2-yn-1-amine 
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Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and dimethyl(prop-2-yne)amine (28 µL, 0.263 mmol, 
1.05 equiv). After 1 h, the reaction mixture was subjected to purification by SCX (MeOH in 3M 
ammonium MeOH) to afford the title compound as a yellow oil (23.6 mg, 60%). 
Xmax (liquid film): 3058, 2941, 2824, 2775, 1690, 1493 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.46±7.42 (m, 2H), 7.32±7.28 (m, 3H), 3.49 (s, 2H), 2.39 (s, 6H). 
13C NMR (CDCl3, 126 MHz): į131.7, 128.3, 128.1, 123.2, 85.4, 84.4, 48.6, 44.2. 
HRMS: exact mass calculated for [M+H]+ (C11H14N) requires m/z 160.1126, found m/z 160.1125. 
Characterisation data is consistent with literature reported values.13 
 
3u: Pent-1-yn-1-ylbenzene 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and 1-pentyne (25.8 µL, 0.263 mmol, 1.05 equiv). After 
1 h, the reaction mixture was subjected to the purification method outlined in the General Procedure 
(silica gel, 0±1% Et2O in petroleum ether) to afford the title compound as a yellow oil (34.5 mg, 
96%). 
Xmax (liquid film): 3058, 2963, 2934, 2872, 2237, 1601, 1491 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.32 (dd, J = 7.5, 1.9 Hz, 2H), 7.22±7.17 (m, 3H), 2.31 (t, J = 7.0 Hz, 
2H), 1.56 (h, J = 7.3 Hz, 2H), 0.98 (t, J = 7.4 Hz, 3H). 
13C NMR (CDCl3, 126 MHz): į131.6, 128.2, 127.5, 124.1, 90.3, 80.7, 22.2, 21.4, 13.6. 
HRMS: exact mass calculated for [M] (C11H12) requires m/z 144.0939, found m/z 144.0941. 
Characterisation data is consistent with literature reported values.14 
 
3v: (Cyclopropylethynyl)benzene 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and ethynylcyclopropane (22 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±1% Et2O in petroleum ether) to afford the title compound as a 
colourless oil (30.3 mg, 85%). 
Xmax (liquid film): 3034, 2924, 2219, 1597, 1513 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.42±7.38 (m, 2H), 7.30±7.26 (m, 3H), 1.47 (m, 1H), 0.91±0.87 (m, 
2H), 0.83 (m, 2H). 
13C NMR (CDCl3, 126 MHz): į 131.6, 128.1, 127.4, 123.9, 93.4, 75.8, 8.6, 0.1. 
Characterisation data is consistent with values reported in the literature.15 
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3w: Prop-1-yne-1,3-diyldibenzene 
 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and 3-phenyl-1-propyne (32.6 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±1% Et2O in petroleum ether) to afford the title compound as a 
colourless oil (38.7 mg, 81%). 
Xmax (liquid film): 3064, 3032, 2924, 1601, 1493 cm1. 
1H NMR (CDCl3, 500 MHz): į7.46 (dd, J = 6.5, 3.0 Hz, 2H), 7.44 (d, J = 7.4 Hz, 2H), 7.36 (t, J = 7.6 
Hz, 2H), 7.32±7.29 (m, 3H), 7.26 (dd, J = 8.8, 5.8 Hz, 1H), 3.85 (s, 2H). 
 13C NMR (CDCl3, 126 MHz): į136.8, 131.7, 128.6, 128.3, 127.9, 127.8, 126.7, 123.7, 87.5, 82.7, 
25.8. 
HRMS: exact mass calculated for [M] (C15H12) requires m/z 192.0939, found m/z 192.0932. 
Characterisation data is consistent with literature reported values.14 
 
3x: (Cyclohex-1-en-1-ylethynyl)benzene 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and 1-ethynylcyclohexene (30.8 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±1% Et2O in petroleum ether) to afford the title compound as an off 
white solid (46.3 mg, quant.). 
Xmax (liquid film): 3062, 2935, 2865, 2204, 1716, 1670 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.39 (dd, J = 7.8, 1.6 Hz, 2H), 7.28±7.23 (m, 3H), 6.20±6.16 (m, 1H), 
2.20 (dd, J = 8.1, 6.0 Hz, 2H), 2.13±2.09 (m, 2H), 1.68±1.63 (m, 2H), 1.61±1.56 (m, 2H). 
13C NMR (CDCl3, 126 MHz): į135.2, 131.4, 128.2, 127.7, 123.8, 120.8, 91.3, 86.8, 29.3, 25.8, 22.4, 
21.6. 
HRMS: exact mass calculated for [M] (C14H15) requires m/z 182.1095, found m/z 182.1102. 
Characterisation data is consistent with literature reported values.15 
 
3y: 1-Methyl-4-(phenylethynyl)benzene 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and p-tolylacetylene (33.2 µL, 0.263 mmol, 1.05 equiv). 
After 1 h, the reaction mixture was subjected to the purification method outlined in the General 
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Procedure (silica gel, 0±1% Et2O in petroleum ether) to afford the title compound as an off white solid 
(46.9 mg, 98%). 
Xmax (liquid film): 3032, 2921, 2219, 1597, 1511 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.53 (dd, J = 7.7, 1.5 Hz, 2H), 7.44 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 
7.3 Hz, 3H), 7.16 (d, J = 7.9 Hz, 2H), 2.38 (s, 3H). 
13C NMR (CDCl3, 126 MHz): į138.4, 131.6, 131.5, 129.1, 128.3, 128.1, 123.5, 120.2, 89.6, 88.7, 
21.5. 
HRMS: exact mass calculated for [M] (C15H12) requires m/z 192.0939, found m/z 192.0942. 
Characterisation data is consistent with literature reported values.2 
 
3z: 1-(Phenylethynyl)-2-(trifluoromethyl)benzene 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and 2-ethynyltrifluorotoluene (36.5 µL, 0.263 mmol, 
1.05 equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±1% Et2O in petroleum ether) to afford the title compound as a 
colourless oil (53 mg, 86%). 
Xmax (liquid film): 3066, 2224, 1312 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.69 (t, J = 8.3 Hz, 2H), 7.57 (dd, J = 6.5, 3.0 Hz, 2H), 7.53 (t, J = 7.5 
Hz, 1H), 7.43 (t, J = 7.7 Hz, 1H), 7.40±7.35 (m, 3H). 
 13C NMR (CDCl3, 126 MHz): į133.7, 131.7, 131.4, 128.8, 128.4, 127.9, 125.9 (q, 3JCF = 5.2 Hz), 
123.6 (q, 1JCF = 273.5 Hz), 122.8, 121.6, 94.9, 85.4. Carbon bearing trifluoromethyl group not 
observed. 
19F NMR (CDCl3, 471 MHz): į-62.35. 
HRMS: exact mass calculated for [M] (C15H9F3) requires m/z 246.0656, found m/z 246.0654. 
Characterisation data is consistent with literature reported values.16 
 
3aa: 2-(Phenylethynyl)pyridine 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and 2-ethynylpyridine (26.5 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±15% EtOAc in petroleum ether) to afford the title compound as a 
yellow oil (43.3 mg, 97%). 
Xmax (liquid film): 3053, 2224, 1582, 1493, 1463 cm-1.  
1H NMR (CDCl3, 500 MHz): į8.62 (d, J = 4.4 Hz, 1H), 7.67 (td, J = 7.7, 1.7 Hz, 1H), 7.60 (dd, J = 
6.5, 3.1 Hz, 2H), 7.52 (d, J = 7.8 Hz, 1H), 7.38±7.35 (m, 3H), 7.26 ± 7.22 (m, 1H). 
 13C NMR (CDCl3, 126 MHz): į150.1, 143.5, 136.2, 132.1, 128.9, 128.4, 127.2, 122.8, 122.3, 89.2, 
88.6. 
HRMS: exact mass calculated for [M+Na]+ (C21H18BF3N2O6SNa) requires m/z 179.0735, found m/z 
179.0731. 
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Characterisation data is consistent with literature reported values.2 
 
3ab: 2-(Phenylethynyl)thiophene 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodobenzene (27.9 µL, 0.25 mmol, 1 equiv), and 2-ethynylthiophene (24.9 µL, 0.263 mmol, 1.05 
equiv). After 1 h, the reaction mixture was subjected to the purification method outlined in the 
General Procedure (silica gel, 0±1% Et2O in petroleum ether) to afford the title compound as an off 
white solid (42.4 mg, 92%). 
Xmax (liquid film): 3088, 2204 cm-1. 
1H NMR (CDCl3, 500 MHz): į±7.50 (m, 2H), 7.35 (m, 3H), 7.31±7.28 (m, 2H), 7.02 (t, J = 4.4 
Hz, 1H). 
13C NMR (CDCl3, 126 MHz): į, 131.4, 128.4, 128.4, 127.3, 127.1, 123.4, 122.9, 93.0, 82.6. 
HRMS: exact mass calculated for [M] (C12H8S) requires m/z 184.0347, found m/z 184.0349. 
Characterisation data is consistent with literature reported values.2 
 
 
 
 
5.5. Products from Scheme 2c 
3ac: 2-Acetyl phenylethynylboronic acid, MIDA ester 
 
 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodoacetophenone (35.8 µL, 0.25 mmol, 1 equiv), and ethynyl boronic acid, MIDA ester (47.5 mg, 
0.263 mmol, 1.05 equiv). After 1 h, the reaction mixture was subjected to the purification method 
outlined in the General Procedure (silica gel, 0±100% EtOAc in petroleum ether) to afford the title 
compound as an off white solid (66.5 mg, 89%).  
Xmax (solid): 2960, 2193, 1770, 1684 cm-1. 
1H NMR (DMSO-d6, 500 MHz): įdd, J = 7.7, 0.9 Hz, 1H), 7.63 (dd, J = 7.6, 0.9 Hz, 1H), 7.57 
(td, J = 7.5, 1.3 Hz, 1H), 7.52 (td, J = 7.6, 1.3 Hz, 1H), 4.34 (d, J = 17.1 Hz, 2H), 4.13 (d, J = 17.1 Hz, 
2H), 3.11 (s, 3H), 2.63 (s, 3H). 
 13C NMR (DMSO-d6, 126 MHz): į, 141.2, 134.6, 131.9, 129.4, 129.2, 120.7, 98.6, 61.9, 
48.4, 29.9. Carbon bearing boron not observed. 
11B NMR (DMSO-d6, 160 MHz): į 
HRMS: exact mass calculated for [M+NH4]+ (C15H18BN2O5) requires m/z 317.1305, found m/z 
317.1303. 
 
3ad: 2-Methyl-phenylethynylboronic acid, MIDA ester 
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Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodotoluene (31.8 µL, 0.25 mmol, 1 equiv), and ethynyl boronic acid, MIDA ester (47.5 mg, 0.263 
mmol, 1.05 equiv). After 1 h, the reaction mixture was subjected to the purification method outlined 
in the General Procedure (silica gel, 0±60% EtOAc in petroleum ether) to afford the title compound as 
an off white solid (62.9 mg, 93%).  
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), DMF (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
iodotoluene (31.8 µL, 0.25 mmol, 1 equiv), and ethynyl boronic acid, MIDA ester (47.5 mg, 0.263 
mmol, 1.05 equiv). After 1 h, the reaction mixture was subjected to the purification method outlined 
in the General Procedure (silica gel, 0±60% EtOAc in petroleum ether) to afford the title compound as 
an off white solid (62.3 mg, 92%).  
Xmax (solid): 3019, 2191, 1770, 1290, 1247 cm-1. 
1H NMR (DMSO-d6, 500 MHz): įd, J = 7.4 Hz, 1H), 7.31±7.27 (m, 2H), 7.22±7.18 (m, 1H), 
4.33 (d, J = 17.1 Hz, 2H), 4.15 (d, J = 17.1 Hz, 2H), 3.09 (s, 3H), 2.40 (s, 3H). 
 13C NMR (DMSO-d6, 126 MHz): į2, 140.3, 132.4, 129.9, 129.3, 126.3, 122.7, 98.7, 61.9, 48.4, 
20.8. Carbon bearing boron not observed. 
11B NMR (DMSO-d6, 160 MHz): į37. 
HRMS: exact mass calculated for [M+NH4]+ (C14H18BN2O4) requires m/z 289.1355, found m/z 
289.1354. 
Characterisation data is consistent with literature reported values.17 
 
3ae: 2-Trifluoromethoxy-phenylethynylboronic acid, MIDA ester 
 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
(trifluoromethoxy)iodobenzene (38.8 µL, 0.25 mmol, 1 equiv), and ethynyl boronic acid, MIDA ester 
(47.5 mg, 0.263 mmol, 1.05 equiv). After 1 h, the reaction mixture was subjected to the purification 
method outlined in the General Procedure (silica gel, 0±60% EtOAc in petroleum ether) to afford the 
title compound as an off white solid (71.8 mg, 85%).  
Xmax (solid): 3016, 2922, 2965, 2198, 1772, 1217, 1024 cm-1. 
1H NMR (DMSO-d6, 500 MHz): įd, J = 7.5 Hz, 1H), 7.55 (t, J = 7.4 Hz, 1H), 7.45 (dd, J = 
16.7, 8.6 Hz, 2H), 4.35 (d, J = 17.2 Hz, 2H), 4.15 (d, J = 17.2 Hz, 2H), 3.09 (s, 3H). 
 13C NMR (DMSO-d6, 126 MHz): į3, 128.3, 121.9, 120.6 (q, 1JCF = 257.4 
Hz), 117.3, 93.5, 62.1, 48.3. Carbon bearing boron not observed. 
11B NMR (DMSO-d6, 160 MHz): į29. 
19F NMR (DMSO-d6, 471 MHz): į-56.54. 
HRMS: exact mass calculated for [M+H]+ (C14H12BF3NO5) requires m/z 342.0763, found m/z 
342.0767. 
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3af: Triisopropyl((2-(trifluoromethoxy)phenyl)ethynyl)silane 
 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M),  Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
(trifluoromethoxy)iodobenzene (38.8 µL, 0.25 mmol, 1 equiv), and (triisopropylsilyl)acetylene (58.9 
µL, 0.263 mmol, 1.05 equiv). After 1 h, the reaction mixture was subjected to the purification method 
outlined in the General Procedure (silica gel, 0±1% Et2O in petroleum ether) to afford the title 
compound as a colouless oil (58.3 mg, 68%). 
Xmax (liquid film): 2947, 2868, 2167, 1491, 1258, 1219, 1169 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.47 (dd, J = 7.6, 1.3 Hz, 1H), 7.28±7.24 (m, 1H), 7.19±7.14 (m, 2H), 
1.06 (s, 21H). 
13C NMR (CDCl3, 126 MHz): į149.8, 134.1, 129.4, 126.6, 121.2, 120.6 (q, 1JCF = 258.1 Hz), 118.3, 
100.4, 97.1, 18.5, 11.2. 
19F NMR (471 MHz, CDCl3): į-57.50. 
HRMS: exact mass calculated for [M] (C18H25F3SiO) requires m/z 342.1627, found m/z 342.1626. 
 
3ag: 2-((Triisopropylsilyl)ethynyl)aniline 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 
mg, 0.005 mmol, 2 mol %), CuI (1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (38 
µL, 0.275 mmol, 1.1 equiv), 2-iodoaniline (54.8 mg, 0.25 mmol, 1 equiv), and 
(triisopropylsilyl)acetylene (58.9 µL, 0.263 mmol, 1.05 equiv). After 1 h, the reaction mixture was 
subjected to the purification method outlined in the General Procedure (silica gel, 0±10% Et2O in 
petroleum ether) to afford the title compound as a yellow oil (45.3 mg, 66%). 
Xmax (liquid film): 3487, 3388, 2945, 2867, 2146, 1616, 1318 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.31 (dd, J = 7.7, 1.1 Hz, 1H), 7.14±7.09 (m, 1H), 6.71±6.64 (m, 2H), 
4.25 (s, 2H), 1.14 (s, 21H). 
13C NMR (CDCl3, 126 MHz): į148.3, 132.4, 129.7, 117.7, 114.1, 108.3, 103.7, 95.9, 18.7, 11.3. 
HRMS: exact mass calculated for [M+H]+ (C17H28NSi) requires m/z 274.1986, found m/z 274.1986. 
Characterisation data is consistent with literature reported values.18 
 
3ah: ((2-Chlorophenyl)ethynyl)triisopropylsilane 
 
 
 
 
Prepared according to General Procedure A using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M),  Et3N (38 µL, 0.275 mmol, 1.1 equiv), 2-
chloro-iodobenzene (30.5 µL, 0.25 mmol, 1 equiv), and (triisopropylsilyl)acetylene (58.9 µL, 0.263 
mmol, 1.05 equiv). After 1 h, the reaction mixture was subjected to purification by reverse phase 
chromatography (C18 cartridge, 20±100% MeCN in water) to afford the title compound as a yellow 
oil (47.7 mg, 65%). 
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Xmax (liquid film): 2945, 2867, 2163, 1472, 1225 cm-1. 
1H NMR (CDCl3, 500 MHz): į7.51 (dd, J = 7.5, 1.6 Hz, 1H), 7.38 (dd, J = 7.9, 0.9 Hz, 1H), 7.23 (td, 
J = 7.7, 1.8 Hz, 1H), 7.19 (td, J = 7.5, 1.2 Hz, 1H), 1.15 (s, 21H). 
 13C NMR (CDCl3, 126 MHz): į136.5, 133.9, 129.4, 126.4, 123.6, 103.3, 96.9, 18.8, 11.5. 
HRMS: exact mass calculated for [M] (C17H25ClSi) requires m/z 292.1414, found m/z 292.1431. 
 
5.6. Cyrene homo-aldol adducts, 4a and 4b 
 
To a stirred solution of Cyrene (256 mg, 2.0 mmol, 1 equiv) was added DBU (30 mg, 0.2 mmol, 0.1 
equiv) and the mixture heated to 100 °C for 10 minutes. The resulting mixture was cooled to 20 °C 
giving a viscous brown oil and then kept at 20 °C for 72 hours over which time the mixture began to 
crystallise. The mixture was then purified by flash chromatography (30% EtOAc/hexanes to EtOAc) 
to give 4a as a colourless oil (40 mg, 16%). 
 
Xmax (neat): 3470, 2962, 2895, 1731 cm-1. 
1H NMR (CDCl3, 500 MHz): į 5.71 (s, 1H), 5.04 (s, 1H), 4.73-4.70 (m, 1H), 4.44-4.41 (m, 1H), 4.01 
(br d, J = 7.4 Hz, 1H), 3.91 (ddd, J = 7.4, 4.9, 1.6 Hz, 1H), 3.83 (d, J = 7.1 Hz, 1H), 3.76 (ddd, J = 
7.1, 5.1, 0.9 Hz, 1H), 3.35 (dd, J = 12.0, 7.4 Hz, 1H), 2.72 (s, 1H), 2.27 (dddd, J = 13.3, 12.0, 3.7, 1.8 
Hz, 1H), 1.96 (ddd, J = 13.3, 7.4, 1.6 Hz, 1H), 1.64-1.59 (m, 3H), 1.50-1.46 (m, 1H). 
13C NMR (CDCl3, 126 MHz): į 203.7, 102.9, 101.6, 73.6, 73.2, 72.9, 68.4, 67.9, 42.7, 32.6, 26.7, 
25.1. 
ESI-MS: m/z 257 (50, [M+H]+), 279 (100, [M+Na]). 
 
To an oven-dried 5 mL microwave vessel was added K3PO4 (637 mg, 3 mmol, 3 equiv). The vessel 
was then capped and purged with N2 before addition of THF (4 mL, 0.25 M), and Cyrene (ȝ/, 1 
mmol, 1 equiv). The reaction mixture was heated to 70 °C and maintained at this temperature with 
stirring for 8 h before the vessel was vented, and decapped. The solution was then diluted with EtOAc 
(20 mL), and washed with water (2 × 20 mL) and brine (2 × 20 mL). The organics were then passed 
through a hydrophobic frit and concentrated under reduced pressure to give an off white solid, which 
was purified by flash chromatography (silica gel, 0±50% EtOAc in petroleum ether) to afford the title 
compound as a white solid (105 mg, 88%). 
 
Xmax (solid): 2898, 1703, 1621, 1098 cm-1. 
1H NMR (CDCl3, 500 MHz): į6.76 (s, 1H), 5.18 (s, 1H), 4.79 (t, J = 5.1 Hz, 1H), 4.60 (t, J = 4.0 Hz, 
1H), 3.94 ± 3.83 (m, 4H), 2.78 (dd, J = 16.3, 2.6 Hz, 1H), 2.56 (d, J = 16.3 Hz, 1H), 2.41-2.24 (m, 
2H), 2.14-2.07 (m, 1H), 1.75 (dd, J = 13.5, 6.5 Hz, 1H). 
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13C NMR (CDCl3, 126 MHz): į190.7, 151.0, 123.4, 101.5, 97.2, 72.6, 72.5, 68.7, 67.8, 34.1, 28.8, 
20.4. 
HRMS: exact mass calculated for [M] (C12H14) requires m/z 238.0841, found m/z 238.0839. 
 
5.7. Products from Scheme 3 
7a: 2-Phenyl-1-tosyl-1H-indole 
 
 
Prepared according to General Procedure B using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (104 µL, 0.75 mmol, 3 equiv), N-(2-
iodophenyl)-4-methylbenzenesulfonamide (93 mg, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 
µL, 0.263 mmol, 1.05 equiv). After 7 h, the reaction mixture was subjected to the purification method 
outlined in the General Procedure (silica gel, 0±15% EtOAc in petroleum ether) to afford the title 
compound as a white solid (78.4 mg, 90%). 
 
Prepared according to General Procedure B using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), DMF (0.5 mL, 0.5 M), Et3N (104 µL, 0.75 mmol, 3 equiv), N-(2-
iodophenyl)-4-methylbenzenesulfonamide (93 mg, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 
µL, 0.263 mmol, 1.05 equiv). After 7 h, the reaction mixture was subjected to the purification method 
outlined in the General Procedure (silica gel, 0±15% EtOAc in petroleum ether) to afford the title 
compound as a white solid (78.6 mg, 91%). 
Xmax (solid): 3073, 1368, 1169 cm-1. 
1H NMR (CDCl3, 500 MHz): į8.33 (d, J = 8.4 Hz, 1H), 7.54±7.50 (m, 2H), 7.45 (t, J = 8.2 Hz, 4H), 
7.38 (t, J = 7.4 Hz, 1H), 7.31±7.28 (m, 3H), 7.06 (d, J = 8.1 Hz, 2H), 6.56 (s, 1H), 2.31 (s, 3H). 
13C NMR (CDCl3, 126 MHz): į144.5, 142.2, 138.3, 134.7, 132.4, 130.7, 130.4, 129.2, 128.7, 127.5, 
126.8, 124.8, 124.3, 120.7, 116.7, 113.4, 21.5. 
HRMS: exact mass calculated for [M+H]+ (C21H18NO6S) requires m/z 348.1058, found m/z 348.1061. 
Characterization data is consistent with literature reported values.3 
 
7b: 5-Nitro-2-phenyl-1-tosyl-1H-pyrrolo[2,3-b]pyridine 
 
 
 
Prepared according to General Procedure B using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (104 µL, 0.75 mmol, 3 equiv), N-(3-
iodo-5-nitropyridin-2-yl)-4-methylbenzenesulfonamide (104 mg, 0.25 mmol, 1 equiv), and 
phenylacetylene (28.8 µL, 0.263 mmol, 1.05 equiv). After 7 h, the reaction mixture was subjected to 
the purification method outlined in the General Procedure (silica gel, 0-30% EtOAc in petroleum 
ether) to afford the title compound as an off white solid (71.4 mg, 73%). 
Xmax (solid): 3070, 2935, 1593, 1517, 1394, 1346, 1184 cm-1. 
1H NMR (CDCl3, 500 MHz): įd, J = 2.4 Hz, 1H), 8.61 (d, J = 2.4 Hz, 1H), 7.85 (d, J = 8.3 Hz, 
2H), 7.55 ± 7.48 (m, 5H), 7.24 (d, J = 8.1 Hz, 2H), 6.63 (s, 1H), 2.37 (s, 3H). 
13C NMR (CDCl3, 126 MHz): į151.3, 145.8, 145.8, 141.4, 140.3, 135.3, 131.5, 129.9, 129.6, 129.6, 
128.2, 127.9, 124.3, 121.4, 108.3, 21.7. 
HRMS: exact mass calculated for [M+H]+ (C20H16N3O4S) requires m/z 394.0862, found m/z 394.0869. 
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7c: 2-Phenylbenzofuran 
 
 
Prepared according to General Procedure B using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (104 µL, 0.75 mmol, 3 equiv), 2-
iodophenol (55 mg, 0.25 mmol, 1 equiv), and phenylacetylene (28.8 µL, 0.263 mmol, 1.05 equiv). 
After 7 h, the reaction mixture was subjected to the purification method outlined in the General 
Procedure (silica gel, 0±1% EtOAc in petroleum ether) to afford the title compound as a white solid 
(43.3 mg, 89%). 
Xmax (solid): 3038, 2924, 2855 cm-1. 
1H NMR (CDCl3, 500 MHz): įd, J = 7.4 Hz, 2H), 7.59 (d, J = 7.5 Hz, 1H), 7.53 (d, J = 8.1 Hz, 
1H), 7.46 (t, J = 7.7 Hz, 2H), 7.36 (t, J = 7.4 Hz, 1H), 7.29 (t, J = 7.7 Hz, 1H), 7.23 (t, J = 7.4 Hz, 
1H), 7.03 (s, 1H). 
13C NMR (CDCl3, 126 MHz): į8, 128.6, 124.9, 124.3, 122.9, 120.9, 
111.2, 101.3 
HRMS: exact mass calculated for [M] (C14H10O) requires m/z 194.0732, found m/z 194.0737. 
Characterization data is consistent with literature reported values.19 
 
7d: (1-Tosyl-1H-indol-2-yl)boronic acid, MIDA ester 
 
 
Prepared according to General Procedure B using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (104 µL, 0.75 mmol, 3 equiv), N-(2-
iodophenyl)-4-methylbenzenesulfonamide (93 mg, 0.25 mmol, 1 equiv), and ethynyl boronic acid, 
MIDA ester (47.5 mg, 0.263 mmol, 1.05 equiv). After 7 h, the reaction mixture was subjected to the 
purification method outlined in the General Procedure (silica gel, 0±80% EtOAc in petroleum ether) 
to afford the title compound as a white solid (87.4 mg, 82%). 
Xmax (solid): 2928, 1763, 1450, 1176, 1038 cm-1. 
1H NMR (DMSO-d6, 500 MHz): į8.12 (d, J = 8.4 Hz, 1H), 7.91 (d, J = 8.2 Hz, 2H), 7.63 (d, J = 7.7 
Hz, 1H), 7.37 (dd, J = 13.1, 8.0 Hz, 3H), 7.25 (t, J = 7.4 Hz, 1H), 7.06 (s, 1H), 4.47 (d, J = 17.5 Hz, 
2H), 4.23 (d, J = 17.4 Hz, 2H), 2.96 (s, 3H), 2.32 (s, 3H). 
13C NMR (DMSO-d6, 126 MHz): į169.6, 145.72, 138.9, 135.5, 130.4, 130.1, 127.08, 125.7, 123.9, 
122.2, 122.0, 114.7, 64.8, 49.9, 21.5. Carbon bearing boron not observed. 
11B NMR (DMSO-d6, 160 MHz): į 
HRMS: exact mass calculated for [M+H]+ (C20H20BN2O6S) requires m/z 427.1139, found m/z 
427.1139. 
Characterization data is consistent with literature reported values.4 
 
7e: (5-Fluoro-1-tosyl-1H-indol-2-yl)boronic acid, MIDA ester  
 
 
 
Prepared according to General Procedure B using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (104 µL, 0.75 mmol, 3 equiv), N-(4-
fluoro-2-iodophenyl)-4-methylbenzenesulfonamide (98 mg, 0.25 mmol, 1 equiv), and ethynyl boronic 
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acid, MIDA ester (47.5 mg, 0.263 mmol, 1.05 equiv). After 7 h, the reaction mixture was subjected to 
the purification method outlined in the General Procedure (silica gel, 0±80% EtOAc in petroleum 
ether) to afford the title compound as a white solid (98 mg, 88%). 
Xmax (solid): 2930, 1750, 1305, 1174, 1040 cm-1. 
1H NMR (DMSO-d6, 500 MHz): įdd, J = 9.2, 4.3 Hz, 1H), 7.91 (d, J = 8.4 Hz, 2H), 7.47 (dd, J 
= 8.8, 2.6 Hz, 1H), 7.40 (d, J = 8.2 Hz, 2H), 7.22 (td, J = 9.2, 2.6 Hz, 1H), 7.06 (s, 1H), 4.48 (d, J = 
17.5 Hz, 2H), 4.24 (d, J = 17.5 Hz, 2H), 2.96 (s, 3H), 2.33 (s, 3H). 
 13C NMR (DMSO-d6, 126 MHz): į6, 159.3 (d, 1JCF = 238.2 Hz), 145.9, 135.4, 135.3, 131.2 (d, 
3JCF = 10.4 Hz), 130.5, 127.1, 121.9, 116.1 (d, 3JCF = 9.4 Hz), 113.5 (d, 2JCF = 25.5 Hz), 107.1 (d, 2JCF 
= 23.5 Hz), 64.8, 49.9, 21.5. Carbon bearing boron not observed. 
11B NMR (DMSO-d6, 160 MHz): į09. 
19F NMR (DMSO-d6, 471 MHz): į-120.04. 
HRMS: exact mass calculated for [M] (C21H18BF3N2O6SNa) requires m/z 444.2966, found m/z 
444.0951. 
Characterization data is consistent with literature reported values.4 
 
7f: (6-Chloro-1-tosyl-1H-indol-2-yl)boronic acid, MIDA ester  
 
 
 
Prepared according to General Procedure B using Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol, 2 mol %), CuI 
(1.9 mg, 0.01 mmol, 4 mol %), Cyrene (0.5 mL, 0.5 M), Et3N (104 µL, 0.75 mmol, 3 equiv), N-(4-
chloro-2-iodophenyl)-4-methylbenzenesulfonamide (102 mg, 0.25 mmol, 1 equiv), and ethynyl 
boronic acid, MIDA ester (47.5 mg, 0.263 mmol, 1.05 equiv). After 7 h, the reaction mixture was 
subjected to the purification method outlined in the General Procedure (silica gel, 0±80% EtOAc in 
petroleum ether) to afford the title compound as a white solid (116 mg, quant.). 
Xmax (solid): 2922, 1763, 1455, 1267, 1173, 1038 cm-1. 
1H NMR (DMSO-d6, 500 MHz): įs, 1H), 7.90 (d, J = 8.4 Hz, 2H), 7.69 (d, J = 8.4 Hz, 1H), 
7.42 (d, J = 8.2 Hz, 2H), 7.34 (dd, J = 8.4, 1.7 Hz, 1H), 7.09 (s, 1H), 4.48 (d, J = 17.5 Hz, 2H), 4.23 
(d, J = 17.4 Hz, 2H), 2.94 (s, 3H), 2.34 (s, 3H). 
 13C NMR (DMSO-d6, 126 MHz): į 169.6, 146.1, 139.3, 135.2, 130.6, 130.4, 128.9, 127.0, 124.4, 
123.4, 121.9, 114.4, 64.7, 49.9, 21.5. Carbon bearing boron not observed. 
11B NMR (DMSO-d6, 160 MHz): į21. 
HRMS: exact mass calculated for [M+Na]+ (C20H18ClN2O6SB) requires m/z 460.0671, found m/z 
460.0658. 
Characterization data is consistent with literature reported values.4 
 
6. Crystallographic Data for Compound 4b 
Single crystal diffraction measurements were made with an Oxford Diffraction Gemini S instrument. 
Refinement was to convergence against F2 and used all unique reflections. Programs used were from 
the SHELX suite.20 Non-hydrogen atoms were refined anisotropically whereas hydrogen atoms were 
placed in idealized positions and refined in riding modes. Selected crystallographic and refinement 
parameters are given in Table 1. CCDC reference number CCDC 1485168 contains the 
supplementary crystallographic data for this paper. This data can be obtained free of charge from The 
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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Table S1 Selected crystallographic data and refinement parameters for compound 4b. 
Compound 4 
Formula C12H14O5 
Mr (g mol
-1) 238.23 
Crystal system monoclinic 
Space group P21 
Temperature (K) 123(2) 
a (Å) 6.4668(2) 
b (Å) 9.8239(3) 
c (Å) 8.5963(2) 
ɴ ?°) 96.341(3) 
V/Å3 542.78(3) 
Z 2 
Wavelength (Å) 0.71073 
Measured reflections 9884 
Unique reflections 3457 
Rint 0.03024 
Observed rflns [I х ?ʍ ?I)] 3286 
ʅ ?ŵŵ-1) 0.114 
No. of parameters 155 
2ɽmax (°) 63.8 
R [on F, obs rflns only] 0.0329 
wR [on F2, all data] 0.0852 
GoF 1.043 
Largest diff.  
peak/hole/e Å-3 
0.242/0.191 
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9. 1H NMR Evidence for the Evaluation of the Base Sensitivity 
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